Drugs / ferric(III)carboxymaltose
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02243735 Comparator | Nov 2014 → Nov 2019 | anemia, colorectal carcinoma | Academic Medical Center - University of Amsterdam | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ferric(III)carboxymaltose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02243735 ↗ |
| Route | Intravenous | “ferric carboxymaltose intravenously” PMID 36863386 ↗ Feb 2023 |